April 25 (Reuters) - Becton Dickinson & Co. (BDX.N: Quote, Profile , Research) said bioMerieux SA (BIOX.PA: Quote, Profile , Research), a maker of healthcare tests, started an arbitration proceeding against its unit over patent rights related to a diagnostic test.
